<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04664712</url>
  </required_header>
  <id_info>
    <org_study_id>ESWT-TP</org_study_id>
    <nct_id>NCT04664712</nct_id>
  </id_info>
  <brief_title>Efficacy of Focused Shock Waves Combined With Adjuvant Therapy With Tendon Supplement</brief_title>
  <official_title>Efficacy of Focused Shock Waves Combined With Adjuvant Therapy With Tendon Supplement in the Treatment of Plantar Fasciitis: a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physical treatment with focused shock waves is effective in the treatment of tendonitis. Food&#xD;
      supplements could facilitate the healing of tendinopathies when combined with shock wave&#xD;
      therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-blind, randomized prospective study (level of evidence IB) was designed. Patients&#xD;
      with plantar fasciitis were recruited and randomized to group A and group B. Group A was&#xD;
      treated with focused shock waves alone and group B with a combination of focused shock waves&#xD;
      and tendon supplement. Pain remission (primary endpoint) and functional recovery (secondary&#xD;
      endpoint) are monitored in both groups at three time points (Months 0, 3, and 6).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 11, 2019</start_date>
  <completion_date type="Actual">November 20, 2020</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Visual Analogue Score (VAS)</measure>
    <time_frame>T0 (recruitment); T1 (three months)</time_frame>
    <description>The pain was quantified using the VAS scale with the scores ranging between 0 (no pain) and 10 (worst imaginable pain).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Visual Analogue Score (VAS)</measure>
    <time_frame>T1 (three months); T2 (six months)</time_frame>
    <description>The pain was quantified using the VAS scale with the scores ranging between 0 (no pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in American Foot &amp; Ankle Score (AOFAS)</measure>
    <time_frame>T0 (recruitment); T2 (six months)</time_frame>
    <description>The scores ranging between 100 (no disability) and 0 (maximum disability)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Foot Function Index (FFI)</measure>
    <time_frame>T0 (recruitment); T2 (six months)</time_frame>
    <description>The scores ranging between 100 (no disability) and 0 (maximum disability).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roles &amp; Maudsley (R&amp;M)</measure>
    <time_frame>T1 (three months)</time_frame>
    <description>Monitorization of the patient's perception of improvement, with the scores ranging from 1 (excellent) to 4 (minimum).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roles &amp; Maudsley (R&amp;M)</measure>
    <time_frame>T2 (six months)</time_frame>
    <description>Monitorization of the patient's perception of improvement, with the scores ranging from 1 (excellent) to 4 (minimum).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Fasciitis, Plantar</condition>
  <arm_group>
    <arm_group_label>shock wave</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>shock wave and tendon supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tendisulfur Pro</intervention_name>
    <description>Dietary supplement based on Methylsulfonylmethane (2.5 g), hydrolyzed collagen (1 g), L-arginine (1 g), L-lysine (500 mg), Vitamin C (500 mg), Bromelain (200 mg), Chondroitin sulfate (150 mg), Glucosamine (150 mg) [17, 18], dry extracts of turmeric (100 mg), Boswellia (100 mg) and Myrrh (50 mg)</description>
    <arm_group_label>shock wave and tendon supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Focused shock wave</intervention_name>
    <description>We delivered 2000 shots per session using a low/medium energy level (range between 0.01 and 0.175 milliJoule/mm2) depending on the patient's tolerance during treatment with a frequency of 4 Hz.</description>
    <arm_group_label>shock wave</arm_group_label>
    <arm_group_label>shock wave and tendon supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  plantar heel pain diagnosed clinically and instrumentally (ultrasound) as plantar&#xD;
             fasciitis, that has not responded to conservative treatment for at least six months;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of previous fractures or ankle and heel surgery;&#xD;
&#xD;
          -  Recurrence of previous local painful episodes;&#xD;
&#xD;
          -  Lesion of the plantar fascia on US examination;&#xD;
&#xD;
          -  Presence of pathologies that affect the function of the foot (lumbar radiculopathy,&#xD;
             Achilles tendinitis, Morton's neuroma, etc.);&#xD;
&#xD;
          -  Chronic inflammatory conditions such as psoriasis, psoriatic arthritis,&#xD;
             spondyloarthritis, ankylosing spondylitis, rheumatoid arthritis, chronic inflammatory&#xD;
             bowel disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Biagio Moretti, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bari Aldo Moro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AOUC Policlinico di Bari - UOC Ortopedia e Traumatologia</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>December 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>focused shock waves</keyword>
  <keyword>tendinitis</keyword>
  <keyword>natriuretics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No sharing</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

